Competing Heterogeneities in Vaccine Effectiveness Estimation

Ariel Nikas,Hasan Ahmed,Veronika I. Zarnitsyna

DOI: https://doi.org/10.3390/vaccines11081312

2023-05-13

Abstract:Understanding waning of vaccine-induced protection is important for both immunology and public health. Population heterogeneities in underlying (pre-vaccination) susceptibility and vaccine response can cause measured vaccine effectiveness (mVE) to change over time even in the absence of pathogen evolution and any actual waning of immune responses. We use a multi-scale agent-based models parameterized using epidemiological and immunological data, to investigate the effect of these heterogeneities on mVE as measured by the hazard ratio. Based on our previous work, we consider waning of antibodies according to a power law and link it to protection in two ways: 1) motivated by correlates of risk data and 2) using a within-host model of stochastic viral extinction. The effect of the heterogeneities is given by concise and understandable formulas, one of which is essentially a generalization of Fisher's fundamental theorem of natural selection to include higher derivatives. Heterogeneity in underlying susceptibility accelerates apparent waning, whereas heterogeneity in vaccine response slows down apparent waning. Our models suggest that heterogeneity in underlying susceptibility is likely to dominate. However, heterogeneity in vaccine response offsets <10% to >100% (median of 29%) of this effect in our simulations. Our methodology and results may be helpful in understanding competing heterogeneities and waning of immunity and vaccine-induced protection. Our study suggests heterogeneity is more likely to 'bias' mVE downwards towards faster waning of immunity but a subtle bias in the opposite direction is also plausible.

Populations and Evolution

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the influence of heterogeneity in vaccine effectiveness estimation. Specifically, the author focuses on how the potential (pre - vaccination) susceptibility and vaccine - response heterogeneity in the population lead to the change of measured vaccine effectiveness (mVE) over time in the absence of pathogen evolution and actual waning of the immune response. This change may be misinterpreted as the actual waning of the immune response, but in fact it may be caused by the heterogeneity within the population.

### Main research questions:
1. **The influence of heterogeneity on vaccine effectiveness**: Explore how the differences in susceptibility and vaccine response among different individuals affect the measurement of vaccine effectiveness.
2. **The direction and degree of heterogeneity**: Simulate the direction and degree of the influence of these heterogeneities on the measured vaccine effectiveness (mVE) through multi - scale agent - based models.
3. **Distinguishing between heterogeneity and waning of the immune response**: Provide methods and theoretical frameworks to help distinguish whether the change in measured vaccine effectiveness is caused by the actual waning of the immune response or by the heterogeneity within the population.

### Specific research contents:
- **Model construction**: Use multi - scale agent - based models, combined with epidemiological and immunological data, to simulate the influence of different types of heterogeneity on vaccine effectiveness.
- **Formula derivation**: Derive concise formulas to describe the influence of these heterogeneities on the hazard rate and the risk ratio, and one of the formulas can be regarded as a generalization of Fisher's fundamental theorem of natural selection.
- **Simulation experiments**: Through simulation experiments, evaluate the influence of heterogeneity under different distributions on vaccine effectiveness estimation, especially the competing effects of baseline susceptibility heterogeneity and vaccine - response heterogeneity.
- **Antibody decay model**: Consider the power - law decay of antibody levels over time and relate it to the protection effect, and explore the influence of this decay on vaccine effectiveness estimation.

### Conclusions:
- **Baseline susceptibility heterogeneity accelerates the apparent waning**: The heterogeneity of baseline susceptibility will lead to an accelerated decline in the measured vaccine effectiveness.
- **Vaccine - response heterogeneity slows down the apparent waning**: The heterogeneity of vaccine response will slow down the decline in the measured vaccine effectiveness.
- **Combined effect**: Baseline susceptibility heterogeneity usually dominates, but vaccine - response heterogeneity can partially offset this effect, and the specific degree depends on the specific distribution situation.

### Significance:
- **Guidance for public policy**: The research results are helpful for more accurate estimation of vaccine - induced protection effects, thus providing a more reliable basis for public health policies.
- **Improvement of research methods**: The methods and formulas provided can be used in future research to help better understand and correct the biases in vaccine effectiveness estimation.

Through these studies, the author hopes to improve the understanding of the influence of heterogeneity in vaccine effectiveness estimation, thus providing scientific support for the accurate assessment of vaccine effects.